Seven Fleet Capital Management LP
CIK 2092021
13F filing for Q2 2026・No. 3,492
- Holdings
- US$605.92M
- Quarter change
- +US$287.66M
- Entries
- 114
- Net bought (estimate)
- —
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
No filing the quarter before to compare with.
Largest holdings
96 stocks worth US$605.92M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| CG ONCOLOGY INCCOM | — | 1,886,236 | US$134.02M | 22.12% |
| TANGO THERAPEUTICS INCCOM | — | 3,228,144 | US$95.66M | 15.79% |
| RVMDREVOLUTION MEDICINES INCCOM | — | 242,029 | US$45.33M | 7.48% |
| PHARVARIS N VCOM | — | 774,501 | US$26.78M | 4.42% |
| LIQUIDIA CORPORATIONCOM NEW | — | 256,603 | US$20.46M | 3.38% |
| ELVNENLIVEN THERAPEUTICS INCCOM | — | 365,386 | US$18.54M | 3.06% |
| ABIVAX SASPONSORED ADS | — | 111,334 | US$14.84M | 2.45% |
| AVALO THERAPEUTICS INCCOM NEW | — | 770,765 | US$14.24M | 2.35% |
| MIRUM PHARMACEUTICALS INCCOM | — | 110,393 | US$12.92M | 2.13% |
| ASSEMBLY BIOSCIENCES INCCOM NEW | — | 433,147 | US$11.9M | 1.96% |
Sign in (free) to see its 50 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 17, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.